Dolutegravir Based Regimens: Safety

Post-CROI 2021 Webinar

Post-CROI 2021 Webinar

Andrew Zolopa, MD, VP, Head, North America Medical Affairs

Post-CROI 2021 Webinar

Andrew Zolopa, MD, VP, Head, North America Medical Affairs

X
DTG: Use in Pregnancy

DTG: Use in Pregnancy

Nneka Nwokolo, Senior Global Medical Director

DTG: Use in Pregnancy

Nneka Nwokolo, Senior Global Medical Director

X
DTG: Metabolic Data Update

DTG: Metabolic Data Update

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

DTG: Metabolic Data Update

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

X
TANGO Study: Metabolic Substudy

TANGO Study: Metabolic Substudy

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

TANGO Study: Metabolic Substudy

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

X
Antiretroviral Therapy and Weight Gain

Antiretroviral Therapy and Weight Gain

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

Antiretroviral Therapy and Weight Gain

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

X

Connect with our Medical Experts

Find my ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Talk to a Medical Expert

Connect now with a live ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1-888-226-8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1-877-844-8872 or FDA at 1-800-332-1088 or www.fda.gov/medwatch